 
                    
            Ora Biomedical Aims to Accelerate Longevity Intervention Research with the Million Molecule Challenge
        Mitchell Lee, CEO of Ora Biomedical, is revolutionizing longevity research with high-throughput screening in C. elegans, aiming to screen over 1 million compounds in    
        
    
        
     
             
                 
                 
                 
                     
                     
                    